Biotech
0
The oligonucleotide synthesis, modification and purification services market is estimated to be worth USD 5.8 billion in 2030

The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and ...

0
The oligonucleotide synthesis, modification and purification services market is projected to be worth USD 5.8 billion

The rapidly growing demand for oligonucleotides, coupled to complex manufacturing procedures and high capital investments required for setting up manufacturing ...

0
The “Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030” report features an extensive study of the current market

To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this link Key Inclusions A detailed assessment of the overall ...

0
Over 60 companies across the globe claim to manufacture drug products / drug substances using the continuous manufacturing technique

The COVID-19 pandemic has severely impaired the overall pharmaceutical supply chain, mostly owing to the absence of workers at manufacturing sites and ...

0
The continuous manufacturing market is projected to grow at an annualized rate of over 15%, till 2030

Roots Analysis has done a detailed study on Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030, covering key aspects of the industry ...

0
The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis

Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch ...

0
The “HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030” report features an extensive study of the current market landscape

To order this detailed 300+ page report, please visit this link Key Inclusions A detailed review of the overall landscape of companies offering ...

0
Close to 120 companies across the globe claim to possess the required expertise and infrastructure to offer contract manufacturing services

Development initiatives of HPAPIs and cytotoxic drugs are generally very demanding, both in terms of experience and capital investment. Most companies ...

0
The HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030

Roots Analysis has done a detailed study on “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020- 2030”, covering key aspects of the industry’s ...

0
HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.

Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on ...

Web Article Services
Logo
Shopping cart